financetom
Business
financetom
/
Business
/
Danone's Oikos yogurt brand enters protein shake market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Danone's Oikos yogurt brand enters protein shake market
May 26, 2025 9:56 AM

NEW YORK, May 16 (Reuters) - Danone introduced

a new protein shake under its Oikos yogurt brand this week as

rivals Fairlife and Chobani that have similar products gain

popularity with consumers and those taking weight-loss drugs

such as Wegovy.

The company is looking to enter the $7 billion protein shake

market, said Shane Grant, global deputy CEO of Danone, in an

interview last month.

"Three-quarters of (U.S. consumers) want more protein in their

diet, and GLP-1s are only accelerating this demand," Grant said,

referring to the weight-loss medications. "We see the explosive

growth across lots of demographics and occasions."

Danone said it spent about one year developing the shake, which

is priced at $3.69.

People taking weight-loss drugs are encouraged to eat more

protein to avoid losing muscle, Reuters has reported, leading to

food makers such as Nestle and Conagra offering

new products high in the nutrients or re-labeling existing ones

to meet the new demand.

Makers of smoothies and shakes have also joined the trend.

Coca-Cola's ultra-filtered milk brand Fairlife, which

offers protein shakes, isn't specifically marketed to people on

GLP-1s, but is growing substantially, Coca-Cola executives have

said in recent calls with Wall Street analysts, helping buoy the

entire company.

Energy-drink maker Celsius in February acquired Alani

Nu, another maker of a popular protein shake.

France-based Danone says the Oikos shake is good for

digestive health because it has five grams of a certain type of

fiber. The company, with the new product, is responding to a

trend of U.S. consumers paying more attention to what they eat.

"We see a larger movement toward nutrition and health as

part of the agenda for the American consumer," Grant said. "We

see that American consumer expectation (of) health through food

as growing."

Grant said he also sees U.S. Health Secretary Robert F. Kennedy

Jr.'s Make American Healthy Again campaign, which is seeking to

overhaul U.S. packaged food and ingredients in it, as part of

that consumer movement.

Danone is turning to social media influencers to help sell

the product, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Visa, Mastercard $30 Billion Swipe-Fee Settlement Rejected by Federal Judge -- Bloomberg
--Street Color: Visa, Mastercard $30 Billion Swipe-Fee Settlement Rejected by Federal Judge -- Bloomberg
Jun 25, 2024
11:14 AM EDT, 06/25/2024 (MT Newswires) -- Price: 274.94, Change: -1.36, Percent Change: -0.49 ...
LifeMD Launching Private Health Insurance Acceptance For Primary Care Services
LifeMD Launching Private Health Insurance Acceptance For Primary Care Services
Jun 25, 2024
11:13 AM EDT, 06/25/2024 (MT Newswires) -- LifeMD ( LFMD ) said Tuesday it's launching private health insurance acceptance for its virtual primary care services, including weight management, with initial availability in select states and ultimately broadening coverage options across all 50 states. As part of its early 2025 roadmap, LifeMD ( LFMD ) said it expects to begin accepting...
Plug Power Says Global BEDP Contracts Hit 7.5 GW
Plug Power Says Global BEDP Contracts Hit 7.5 GW
Jun 25, 2024
11:11 AM EDT, 06/25/2024 (MT Newswires) -- Plug Power ( PLUG ) said Tuesday it has received global Basic Engineering and Design Package, or BEDP, contracts for a total of 7.5 gigawatts. Among its recent contracts is with Allied Green Ammonia for a 3 GW electrolyzer project in Australia, Plug Power ( PLUG ) said. Shares of Plug Power (...
Kane Biotech Signs License Agreement with I-MED Pharma
Kane Biotech Signs License Agreement with I-MED Pharma
Jun 25, 2024
11:06 AM EDT, 06/25/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) on Tuesday said it entered into a worldwide license agreement with Montreal-based I-MED Pharma for the DispersinB technology. Kane, which specializes in treatments for microbial biofilms. said the agreement is the first for its DispersinB product. Biofilm is a contributor to Meibomian gland dysfunction and dry eye blepharitis...
Copyright 2023-2026 - www.financetom.com All Rights Reserved